| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.2M | — | +102.1% |
| Cost of Revenue | $2.1M | — | -24.5% |
| R&D Expense | $11.4M | — | -11.5% |
| SG&A Expense | $9.8M | — | -20.8% |
| Operating Income | -$8.0M | — | +60.7% |
| Pre-tax Income | -$8.7M | — | +58.1% |
| Income Tax | $36K | — | +227.3% |
| Net Income | -$8.7M | — | +57.9% |
| EPS (Basic) | -$0.10 | — | +60.0% |
| EPS (Diluted) | -$0.10 | — | +60.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.6M | -28.0% | +99.6% |
| Short-term Investments | $28.6M | +4.2% | -31.1% |
| Inventory | $2.0M | +10.1% | +12.3% |
| Current Assets | $79.6M | -17.7% | +2.4% |
| Total Assets | $129.4M | -12.5% | +0.4% |
| Current Liabilities | $14.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.2M | — | +4.7% |
| Capital Expenditures | $176K | — | -86.0% |
| Investing Cash Flow | -$1.1M | — | -109.4% |
| Financing Cash Flow | -$14K | — | -101.3% |
| Free Cash Flow | -$13.3M | — | +11.5% |
| -29.0% |
| Long-term Debt | $40.5M | +0.9% | +38.7% |
| Total Liabilities | $86.1M | -11.4% | +8.7% |
| Stockholders' Equity | $43.2M | -14.4% | -12.9% |